Sunday, March 03, 2013 4:34:27 PM
ASNB - 10q out 2/13/13. Solid improvement, the first profitable quarter for them in a while. From it:
"Total revenues for the three months ended December 31, 2012 were $869,000 as compared with $356,000 for the prior year period, an increase of $513,000, or 144.1%.
Product sales of our biomaterials for the three months ended December 31, 2012 were $440,000 as compared with $179,000 for the prior year period, an increase of $261,000, or 145.8%. The increase is due to the growth in sales from existing and new customers."
"Gross profit on total revenues for the three months ended December 31, 2012 was $673,000, or 77.4% of total revenues, compared with $152,000, or 42.7% of total revenues, for the prior year period. The increase in gross profit dollars and gross profit as a percentage of total revenues is primarily due to the effect of the royalty and product minimums recognized during the three months ended December 31, 2012, as previously described, and the increase in product sales.
Gross profit on product sales for the three months ended December 31, 2012 was $244,000, or 55.5% of product sales, compared with ($25,000), or (14.0%) of product sales, for the prior year period. The improvement in gross profit dollars and gross profit as a percentage of product sales is primarily due to continued improvement in our manufacturing cost structure and efficiencies in our manufacturing processes combined with the increase in product sales. We believe our efforts to improve manufacturing overhead costs and processes have stabilized, and future growth in product sales, which future growth cannot be assured, should benefit gross profit on product sales."
And this product, "The Wand" by Access Scientific, is coated with ASNB polymers. Access Scientific recently purchased by a hedge fund who will provide funding to help launch The Wand. Very, very meaningful to ASNB's future.
http://www.accessscientific.com/
http://www.accessscientific.com/pdf/PR-0023_A.pdf
Great reviews for The Wand:
http://www.accessscientific.com/pdf/PR-0019_A.pdf
http://www.accessscientific.com/pdf/PR-0020_A.pdf
"Total revenues for the three months ended December 31, 2012 were $869,000 as compared with $356,000 for the prior year period, an increase of $513,000, or 144.1%.
Product sales of our biomaterials for the three months ended December 31, 2012 were $440,000 as compared with $179,000 for the prior year period, an increase of $261,000, or 145.8%. The increase is due to the growth in sales from existing and new customers."
"Gross profit on total revenues for the three months ended December 31, 2012 was $673,000, or 77.4% of total revenues, compared with $152,000, or 42.7% of total revenues, for the prior year period. The increase in gross profit dollars and gross profit as a percentage of total revenues is primarily due to the effect of the royalty and product minimums recognized during the three months ended December 31, 2012, as previously described, and the increase in product sales.
Gross profit on product sales for the three months ended December 31, 2012 was $244,000, or 55.5% of product sales, compared with ($25,000), or (14.0%) of product sales, for the prior year period. The improvement in gross profit dollars and gross profit as a percentage of product sales is primarily due to continued improvement in our manufacturing cost structure and efficiencies in our manufacturing processes combined with the increase in product sales. We believe our efforts to improve manufacturing overhead costs and processes have stabilized, and future growth in product sales, which future growth cannot be assured, should benefit gross profit on product sales."
And this product, "The Wand" by Access Scientific, is coated with ASNB polymers. Access Scientific recently purchased by a hedge fund who will provide funding to help launch The Wand. Very, very meaningful to ASNB's future.
http://www.accessscientific.com/
http://www.accessscientific.com/pdf/PR-0023_A.pdf
Great reviews for The Wand:
http://www.accessscientific.com/pdf/PR-0019_A.pdf
http://www.accessscientific.com/pdf/PR-0020_A.pdf
Recent NORD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 07:42:23 PM
- Nordicus Partners Corporation Corporate Update • GlobeNewswire Inc. • 02/06/2026 04:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 06:28:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 08:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 02:00:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 06:08:32 PM
- NoviThera has initiated the first efficacy animal studies • GlobeNewswire Inc. • 11/13/2025 04:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2025 08:05:16 PM
- Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats. • GlobeNewswire Inc. • 10/22/2025 01:00:00 PM
- Orocidin develops novel cGMP manufacturing process in collaboration with Syngene • GlobeNewswire Inc. • 10/20/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/14/2025 01:00:24 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 10/14/2025 01:00:23 PM
- Nordicus Partners Corporation Announces The Formation Of A New Company, NoviThera ApS • GlobeNewswire Inc. • 10/03/2025 08:38:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2025 01:43:00 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2025 10:07:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 06:45:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2025 01:38:25 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/05/2025 06:43:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/29/2025 07:21:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2025 12:01:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/01/2025 07:55:13 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/27/2025 01:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 01:00:36 PM

